Cardiometabolic Disorders

Top Story

Greater CV benefit with canagliflozin vs. other diabetes drugs

February 19, 2018
In the Journals Plus

Fasting insulin, insulin resistance may predict weight gain over 10 years

February 17, 2018
In a population-based cohort, each 1 µU/mL increase in fasting insulin level was associated with an average half-pound increase in body weight over 10 years, whereas…
In the Journals Plus

Diabetes in takotsubo syndrome increases mortality rates

February 16, 2018
Adults with takotsubo syndrome and diabetes had higher rates of mortality, hypertension and severely impaired left ventricular ejection fraction compared with those with…
In the Journals Plus

As obesity-related health costs rise, experts warn of far-reaching complications

February 15, 2018
Obesity-related health care costs in the United States rose 29% between 2001 and 2015, and new data from the most populous states reveal that the cost burden varies…
More Headlines »

What You Need to Know About Familial Chylomicronemia Syndrome: Pathophysiology, Diagnosis, Management, and the Patient Perspective

This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Lipid Association.

Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia and…
More »
Meeting News

VIDEO: Certain antiplatelet therapies more beneficial for patients with vs. without diabetes

July 15, 2017
More »
Resource Centers



Understanding and Managing a Complex Dual Dilemma: Diabetes and Dyslipidemia

This activity is supported by an educational grant from Amgen.

Patients with type 2 diabetes have increased cardiovascular risk. Inhibitors of proprotein convertase subtilisin/kexin…
More »